0001793229-26-000052
SEC filingClaritev received a grand jury subpoena from the DOJ in August 2024 and is cooperating, responding to an article alleging a criminal antitrust probe.
The filing addresses an article published on May 14, 2026 alleging that the DOJ has launched a criminal antitrust probe into Claritev. The company discloses that it received a grand jury subpoena from the Antitrust Division in August 2024 in connection with an investigation regarding health insurance. Claritev states it is cooperating fully and that the DOJ has not informed the company that it is a target of the investigation. This clarification is furnished under Item 7.01 and is not deemed filed for Exchange Act purposes.